Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

Hyperthermia with 44 degrees C enhances danger signal-mediated activation of dendritic cells, while immune cell infiltration into tumors is particularly fostered by hyperthermia with lower temperatures (2017) Vogl P, Frey B, Rueckert M, Maueröder C, Fietkau R, Gaipl U, Derer A Conference contribution Electrothermic effects of microwave heating on B16 melanoma cells - examinations with a semi-continuous plug flow-like reactor (2017) Drescher C, Derer A, Rosin A, Gerdes T, Willert-Porada M, Wadepohl M, Fietkau R, et al. Conference contribution IMMO-LDRT01: Immunophenotyping of patients suffering from chronic degenerative joint diseases and receiving local low-dose radiation therapy (2017) Harrer A, Rühle PF, Gryc T, Ott OJ, Fietkau R, Gaipl U, Frey B Conference contribution Erlangen Experience on radiosurgical Treatment for Trigeminal Neuralgia (2017) Lettmaier S, Putz F, Distel L, Bischoff B, Bozhkov Y, Merkel A, Lambrecht U, et al. Conference contribution Influence of radiotherapy-induced reactive oxygen species on the immunogenic potential of HPV+ in comparison to HPV- HNSCC (2017) Peitz L, Frey B, Rieckmann T, Fietkau R, Gaipl U Conference contribution Immunological basis of local and abscopal antitumor responses induced with radio-immunotherapy (2017) Rueckert M, Frey B, Fietkau R, Gaipl U Conference contribution Interactions between radiotherapy and immunotherapy (2017) Rueckert M, Fietkau R, Frey B, Gaipl U, Deloch L Journal article A clinician's plea to test glioma patients for CMV (2017) Goerig N, Frey B, Überla K, Gaipl U, Fietkau R Journal article Influence of patient mispositioning on SAR distribution and simulated temperature in regional deep hyperthermia (2017) Aklan B, Gierse P, Hartmann J, Ott OJ, Fietkau R, Bert C Journal article Idelalisib may have the potential to increase radiotherapy side effects (2017) Gryc T, Putz F, Goerig N, Ziegler S, Fietkau R, Distel L, Schuster B Journal article